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ABSTRACT 
Bitter almond is one of the medicinal plants that have been used to prevent and treat diseases since many 
centuries ago. Bitter almond essential oil can be effectively used to heal wounds, hemorrhoids and hair loss, relieve 
joint pain, facilitate delivery, and strengthen and condition hairs. Moreover, oral use of bitter almond seed has 
been demonstrated to cause antioxidant, antibacterial, and anticancer effects because of containing certain 
compounds such as amygdalin. However, there have been some challenges in investigations conducted to discover 
bitter almond-based oral, herbal drugs to treat different diseases such as cancer because of cyanide-induced 
poisoning, partly precluding use of this plant. This study was conducted to comprehensively review the traditional 
uses, phytochemical compounds, and therapeutic actions of bitter almond and its compound as well as the side 
effects due to use of them. 
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INTRODUCTION 
Worldwide, plants have long been used to treat many 
diseases [1]. The local people of different regions 
across the world have been using different parts of 
medicinal plants, as infusion, decoction, incense, and 
poultice to prevent and treat diseases [2-8]. In recent 
studies, the researchers, inspired by traditional uses of 
these plants, have examined their effects on many 
disorders [9-15]. The plants and their compounds, 
which demonstrated to have optimal actions, have 
been used to develop pharmaceutical products in 
modern medicine, because of several therapeutic 
effects and few side effects [16-26]. Medicinal plants 
are compatible with the body's immunity system 
because of being nature-based [27-30]. Almond is a 
plant-based product which is useful to human beings' 
health [31]. Almond tree is native to the 
Mediterranean region of Asia and has been cultivated 
in central and western Asia [32]. It may reach to a 
height of 6-8 m and belongs to family Rosaceae.  
Almond has two varieties, non-bitter and bitter [32, 
33]. Non-bitter almond (Sweet almond) is the fruit 
of a tree called Prunus amygdalus var. dulcis with 
very low amounts of toxic phytochemicals. Bitter 
almond is the fruit of Prunus amygdalus var. amara 
that contains comparably greater amounts of toxic 
phytochemicals called glycoside amygdalin [34, 35], 
such that its excessive use (toxic tolerable doses for 
human being) can lead to poisoning and even death 
[36]. Bitter almond has pink shoots and relatively 
flatter and shorter fruits than non-bitter almond 
that has white shoots [37].  
Although bitter almond has various health benefits 
[34], it has adverse and toxic effects on the body 
because of containing hydrocyanic acid which is the 
reason for the bitter taste of bitter almond [38, 39]. 
Many studies have been conducted to investigate 
the benefits of bitter almond to prevent and treat 
diseases.  
Studies have demonstrated that use of bitter almond 
seed or essential oil can help to prevent stretch marks 
in pregnancy [40] and to inhibit tumor growth [41]. 
Moreover, almond seed extract exerts antioxidant and 
antibacterial properties [42]. However, according to 
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some studies, it cannot be definitely argued that oral 
use of bitter almond and the products derived from it 
causes anticancer actions [43, 44]. Regarding the 
traditional uses and therapeutic effects of bitter 
almond according to available evidence, and the 
lacking of comprehensive study on the therapeutic 
properties of bitter almond with regard to its 
compounds, we conducted this review article to 
explore the phytochemical and phytotherapeutic 
properties of bitter almond.  
In this study, we searched for amygdalin, Prunus 
amygdalus var. amara and bitter almond, as search 
terms, in the abstracts of the articles indexed in PubMed 
till 30 March, 2016 using EndNote software and then 
retrieved articles with these two terms appearing in their 
abstracts. The abstracts were reviewed according to 
predetermined inclusion and exclusion criteria. The full 
texts of the articles were examined to assess study 
eligibility if needed. The articles without English 
abstracts as well as accessible English full texts were 
excluded. Only the articles that mainly investigated the 
phytotherapeutic effects and phytochemical compounds 
of bitter almond were included. Other materials related 
to the subject under study were manually searched for in 
reliable references in libraries. 
 
Phytochemical characteristics 
As with non-bitter almond, bitter almond kernel 
contains various nutrients such as minerals, vitamins, 
and fatty acids. The major bioactive components of 
bitter almond are prunasin, amygdalin, flavonoid and 
phenolic acids which exert anticancer and antioxidant 
effects. However, available information is inadequate 
about the pharmacokinetics of amygdalin and other 
compounds in bitter almond. 
Nutritional value 
Chemical composition of bitter almond can be 
detected by a variety of techniques such as inductively 
coupled plasma mass spectrometry (ICP-MS) [45]. The 
amount of nutrient in almond depends on the region 
of occurrence and species. In addition to fat and many 
amino acids, bitter almond contains minerals, such as 
Zn, Mg, Fe, Ca, and K, and vitamins, particularly 
vitamin E [46]. Bitter almond kernel contains 
approximately 48% fat, 30% protein, 60% 
carbohydrates, 3% amygdalin, and some other 
nutrients [47]. Moreover, according to Li et al study on 
bitter almond nutrients, bitter almond kernel contains 
49.6% fat and 94.84% of its fatty acids were 
unsaturated. In addition, the kernel was found to 
contain 27% protein, 26.72% amino acids (17 amino 
acids in total), and 7.57% essential amino acids [48]. 
The major fatty acids of bitter almond kernel are oleic 
acid (70.61%) and linoleic acid (20.68%). Bitter 
almond kernel is considered a valuable source of lipid 
soluble vitamins [vitamin D (1.40 mg/kg), vitamin K 
(42.25 mg/kg) and saturated fatty acids (7.85 mg/kg), 
and unsaturated fatty acids (92.15 mg/kg)] [49]. Bitter 
almond has a large number of nutrients [35] However, 
use of excessive (more-than safe amounts) amounts of 
bitter almond, depending on age and body mass index, 
can cause cyanide-induced complications in human 
[50]. 
Phytochemical investigations 
Bitter almond has a unique smell due to 3-
methylbutanal and 2-methylbutanal present in its seed 
[51]. Almond contains also polyphenolic compounds, 
especially flavonoids that exist in different organs [52, 
53]. Flavonoid compounds, including myricetin, 
naringenin and kaempferol, and phenolic acids like 
vanillic acid, caffeic acid, ferulic acid, hydroxycinnamic 
acid, rosmarinic acid, and proanthocyanidin 
compounds are found in the extract of bitter almond. 
Moreover, bitter almond is a good natural 
source of phenolic compounds (674.40 mg GAE/g in 
total), phytosterols [stigmasterol (242.65 mg/kg), β-
sitosterol (366.95 mg/kg), ergosterol(0.65 mg/kg), α-
tocopherol (104.15 mg/kg), δ-tocopherol (4.95 mg/kg), 
and retinol (0.05 mg/kg)] [49]. Prunasin and amygdalin 
are the main compounds of bitter almond. 
Prunasin is a cyanogenic monoglucoside found in 
many organs of almond [54]. To synthesize amygdalin, 
different concentrations of prunasin are required in 
fruit. The difference in these concentrations 
determines whether ripened almond is bitter or non-
bitter [37]. A set of genes is involved in the 
development of different properties in bitter almond 
and sweet almond [55]. Prunasin forms at the 
beginning of fruit development and converts to 
diglucoside amygdalin throughout the process of 
nuclear development and maturation [56]. Prunasin 
lacks the second sugar in amygdalin structure that is 
present in green almond and is converted to 
amygdalin throughout the process of fruit ripening 
[39, 57]. At anthesis, the almond and the flax fruits 
contain the monoglucosides prunasin, and linamarin 
and lotaustralin, respectively, while, at maturity, only 
the corresponding diglucosides amygdalin, linustatin 
and neolinustatin are found, respectively [57]. 
Cyanide compounds differ in various organs of bitter 
almond tree. Dicenta et al investigated the cyanogenic 
compounds, amygdalin and prunasin, in kernel, leaves, 
and root of non-bitter, semi-bitter, and bitter almond 
trees. They found that prunasin existed only in the 
roots and leaves of all the studied genotypes and in all 
roots. But, only the genotypes of bitter almond are 
able to convert prunasin amygdalin in almond kernel 
[58]. In bitter almond, the beta-glucosidase activity 
was low in the inner epidermis in the tegument facing 
the nucellus. These data, taken together, show that in 
the bitter genotype, prunasin synthesized in the 
tegument is transferred into the cotyledon through the 
transfer cells and converted into amygdalin in the 
developing almond seed. 
The prunasin turnover may offer a buffer supply of 
ammonia, aspartic acid, and asparagine that enables 
the plants to balance the supply of nitrogen to the 
developing cotyledons [39].  
Cyanogenic glycosides are produced by many plants 
and produce cyanide hydrogen via hydrolysis [59]. 
This process is referred to as cyanogenesis which 
happens in bitter almond kernel [34]. Bitter almond 
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contains a cyanogenic diglucoside compound, 
amygdalin (D-mandelonitrile-b-gentiobioside) (Figure 
1). Amygdalin is the cause of bitter taste of almond 
kernel [37, 58], and because amygdalin decomposes 
into cyanuric acid, its use can cause poisoning-induced 
complications and lead to death [60]. Amygdalin can 
produce certain substances such as glucose, 
benzaldehyde, and cyanide hydrogen through 
hydrolyzing an enzyme called β-glucosidases [39] or 
acid hydrolysis [50]. 
Amygdalin concentration varies depending on the 
species of almond and other factors. Amygdalin is also 
found in the other plants from family Rosaceae, such 
as peach and apricot. Studies indicate that the 
phenotype and the region of cultivation can affect the 
amount of amygdalin in kernel, such that amygdalin 
concentration is 2.16-157.44 mg/kg in non-bitter, 
523.50-1772.75 mg/kg in semi-bitter, and 33006.60-
53998.30 mg/kg in bitter almonds [61]. Moreover, 
amygdalin concentration increases as fruit develops 
[37]. Hydrocyanic acid concentration of bitter almond 
is approximately 40 times higher than that of non-
bitter almond [34]. 
Phytotherapeutic properties 
Traditional uses of bitter almond 
Bitter almond is highly valuable in traditional and 
modern medicine [48]. In Iranian traditional medicine, 
bitter almond essential oil is used to treat burns and 
wounds and to protect stomach [62]. Moreover, 
according to Iranian traditional medicine, bitter 
almond ointment or essential oil is used to treat acne, 
joint pain, hair loss, to facilitate delivery, and to 
strengthen and condition hairs. In addition, the 
physicians of old Iran made a bitter almond-based 
remedy to treat hemorrhoids [63]. 
Antioxidant properties 
Almond contains some phytochemicals with 
antioxidant properties [52]. Flavonoid and phenolic 
compounds are accumulated in 15.198 mg/g in bitter 
almond skin and kernel [53]. Some studies extensively 
investigating the antioxidant properties and 
compounds of bitter almond, demonstrated that bitter 
almond extract contains flavonoid (22.98 mg/g in 
total), suggesting the kernel of bitter almond has great 
antioxidant properties [49]. In Gomma study [42], 
mean antioxidant capacity of aqueous, methanolic, and 
ethanolic extracts was derived 56.72, 44.86, and 33.05 
mg/g dry extract, respectively. In addition, the highest 
amount of phenolic compounds was reported to exist 
in aqueous extract and the highest amount of 
flavonoid compounds and lycopene in the ethanolic 
extract of bitter almond kernel. Moreover, bitter 
almond is rich in fat soluble vitamins. Vitamin E is one 
of the vitamins that can exert optimal antioxidant 
effects and is found abundantly in the seed kernel of 
this plant [49]. 
Anticancer properties 
Amygdalin, one of the most important compounds of 
bitter almond, was referred to as B17 or laetrile in the 
last decades and has been known to be a unique 
substance to treat cancer for over 100 years [64]. 
Cyanide in laetrile or chemically referred to as 
amygdalin is thought to be the cause of anticancer 
properties that can contribute to treating different 
cancers [65] (Table 1). Amygdalin was considered an 
unconventional but desired anticancer agent in 1970s 
[66]. Gomaa study demonstrated that aqueous, 
methanolic, and ethanolic extracts of bitter almond 
kernel can inhibit the growth of cancer cell lines 
HepG2, HCT-116, and MCF-7 in a dose-dependent 
manner with different susceptibilities among these 
cell lines [42]. A study on amygdalin effect on the 
growth of a number of cancer cell lines indicated that 
amygdalin might inhibit tumor growth by down-
modulating cdk2 and cyclin in vitro [41]. 
Furthermore, anticancer effects of amygdalin have 
been investigated on hepatocarcinoma and colon, 
bladder, and cervical cancers [67-72]. The findings 
demonstrated that amygdalin is an anticancer agent 
that can induce apoptosis and inhibit adhesion of cells 
[73]. Moreover, amygdalin can be used as a 
chemopreventive agent to prevent or alleviate 
progression of cancers.  
Besides that, Qian et al reported the anti-metastatic 
properties of amygdalin in lung cancer patients. They 
indicated that low doses of amygdalin had weaker 
inhibitory effects on cancer cells and this effect on the 
cells increased with increase in the administered dose 
[68] (Table 1). However, increased doses are more 
likely to cause cyanide-induced poisoning.  
In this regard, a review article published in 2011 
reported that laetrile or amygdalin could not be much 
useful to treat cancer patients because the risk of 
cyanide-induced poisoning due to amygdalin especially 
if amygdalin is administered orally [74]. Besides that, a 
study on clinical benefits of amygdalin did not strongly 
suggest that amygdalin be used as an anticancer drug in 
the light of its benefits vs. the risks potentially induced 
by it [70]. 
Despite of previous studies for evaluating the effects of 
bitter almond and its compounds on cancers, there is 
still debate about anticancer effects of amygdalin 
because this compound has not yet been adequately 
investigated in clinical trials [65]. Cyanide compounds 
can cause cell necrosis through antibody-guided 
enzyme nitrile therapy, such that enzymatic catalysis of 
the substrate generates cyanide, a metabolic poison 
that asphyxiates cells and causes a necrotic-like cell 
death. This system is referred to as antibody-
guided enzyme nitrile therapy [76]. Moreover, these 
compounds may cause intracellular hypoxia through 
reversibly binding to mitochondrial c cytochrome C 
oxidase, the terminal enzyme in the mitochondrial 
respiration chain, and suspend adenosine triphosphate 
synthesis, and consequently lead to cell suffocation and 
death [77, 78]. However, it can be definitely argued that 
amygdalin, present in bitter almond, can exert 
considerable anticancer effects on different cancer cells 
through certain mechanisms such as inhibition of cell 
cycle and induction of apoptotic and anti-metastatic 
actions. But, anticancer effects of bitter almond have 
been less frequently studied in animals and humans 
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because large amounts of this plant may lead to 
cyanide-induced poisoning because of containing large 
amounts of amygdalin [79]. FDA has banned amygdalin 
use since 1980 and European countries have prohibited 
its sale [69]. However, amygdalin is still being used as 
an anticancer agent in some regions worldwide [80, 
81]. Therefore, it is essential to investigate the effect of 
amygdalin on normal cells death and then in laboratory 
animals to find a dose with anticancer effects but 
without fatal effects on normal cells and non toxic to 
humans. 
Prevention of stretch marks  
In pregnancy, mechanical tension can damage the 
connective tissue of the dermis, and plant-based oils 
can play a preventive role in this condition [82]. 
Massaging with bitter almond essential oil can help to 
prevent stretch marks, but the evidence is weak on the 
effect of bitter almond essential oil or other bitter 
almond-based products in preventing stretch marks or 
alleviating its severity [44]. To the best of our 
knowledge, only one study demonstrated that 15-min 
massaging with bitter almond essential oil prevented 
the progression of stretch marks. However, this oil 
exerted no therapeutic effects [40]. 
 
 
Figure 1. Chemical structure of amygdalin and prunasin, 
reproduced from [25]. 
Table 1. Anticancer properties of bitter almond and amygdalin 
Ref. Main results Dosage Type of extract/ Active compound Type of cancer 
[71] Down-regulation of cell cycle-related genes in SNU-C4 human colon cancer cells. 0.25-5 mg/ml 
Amygdalin 
Colon cancer 
[72] 
Amygdalin inhibited proliferation of MCF7, MDA-MB-231, and 
Hs578T cells (IC50 values of amygdalin in MCF7, MDA-MB-231, and 
Hs578T cells were 30.8, 48.5 and 52.9 mg/mL, respectively); 
regulated apoptosis-related proteins and signaling molecules; also 
inhibited adhesion of Hs578T cells. 
2.5-80 mg/mL Breast cancer 
[41] 
Amygdalin reduced growth and proliferation in a dose-dependent 
manner in all studied bladder cancer cell lines by delaying cell cycle 
progression and G0/G1 arrest. 
1.25-10 mg/ml Bladder Cancer 
[73] Inhibited the growth of HeLa cell xenografts through a mechanism of apoptosis. 
1.25-20 
mg/mL Cervical cancer 
[65] 
Induced apoptotic cell death in human DU145 and LNCaP prostate 
cancer cells by caspase-3 activation through down-regulation of 
Bcl-2 and up-regulation of Bax. 
0.01-10 mg/ml Prostate cancer  
[68] Amygdalin was likely to have anti-metastatic NSCLC effect. 2.5-5 mg/ml Lung cancer 
[42] 
Cytotoxicity activity (IC50= 29.5 µg) 
1.56-50 µg/ml 
Aquous extract Breast carcinoma 
cell line (MCF-7) Cytotoxicity activity (IC50= 31.4 µg) Ethanolic extract 
Cytotoxicity activity (IC50= 24.5 µg) Aquous extract Colon carcinoma 
cell line (HCT-116) Cytotoxicity activity (IC50= 45.7 µg) Methanolic extract Cytotoxicity activity (IC50= 39.4 µg) Ethanolic extract 
Cytotoxicity activity (IC50= 11.9 µg) Aquous extract Hepatocellular 
carcinoma cell line 
(Hep-G2) 
Cytotoxicity activity (IC50= 10.1 µg) Methanolic extract 
Cytotoxicity activity (IC50= 17.4 µg) Ethanolic extract 
 
Table 2. Antibacterial properties of bitter almond extract 
Minimum inhibitory 
concentration (MIC) Extract type 
Type of 
Microorganism 
2.5 mg/ml Aqueous Bacillus subtilis  
ATCC 6633 
 
0.625 mg/ml Methanolic 
2.5 mg/ml Ethanolic 
1.25 mg/ml Methanolic Staphylococcus aureus 
NCTC 7447 
10 mg/ml Ethanolic 
5 mg/ml Methanolic Salmonella typhi NCIMB 9331 
 
The reviewed studies indicate that bitter almond 
essential oil can be used to prevent stretch marks. This 
may be explained by the fact that almond kernel 
contains large amounts of fat soluble vitamins such as 
vitamin E, because vitamin E, a strong antioxidant, 
contributes significantly to reducing the extent and 
severity of skin pathological complications [83]. 
Consistent with this argument, some studies reported 
vitamin E-contained emulsions and creams to be 
effective in preventing and relieving stretch marks [84]. 
Moreover, the presence of flavonoids and phenolic 
compounds, as antioxidant compounds, in bitter 
almond confirms prophylactic and relieving effects on 
stretch marks-induced skin complications. However, 
the therapeutic effects of these compounds have not 
yet been confirmed. 
Antimicrobial properties  
Investigations on antibacterial properties of bitter 
almond indicate that the extract of bitter almond seed 
is effective in decreasing Bacillus cereus colonies and 
tracing the active toxin of this bacterium in foods. This 
effect is reinforced if bitter almond is combined with 
International Journal of Pharmaceutical and Phytopharmacological Research (eIJPPR) | April 2017 | Volume 7 | Issue 2 | Page 1-9 
Asadi-Samani M., A Systematic Review of Phytochemical and Phytotherapeutic Characteristics of Bitter Almond 
ISSN (Online) 2249-6084 (Print) 2250-1029                                                                                       www.eijppr.com 
5 
other plants such as green tea [85]. Different extracts 
of bitter almond can exert different antimicrobial 
effects. Of these extracts, methanolic extract was found 
to exert more optimal effects on Bacillus subtilis and 
Staphylococcus aureus [42](Table 2). Few studies have 
yet confirmed the antimicrobial effects of bitter 
almond. Moreover, the studied extracts were found to 
be effective on a limited number of bacteria, or were 
not able to exert optimal inhibitory effects on at least a 
specific bacterium. Comprehensive studies are needed 
to determine the minimum bactericidal concentration 
(MBC) of bitter almond extracts on bacteria. 
Side effects  
Many people around the world are accidentally 
poisoned by plant-based cyanide compounds [34]. The 
fruits and kernel of different species of almond can 
produce these compounds. The amounts of cyanide 
compounds are much higher in P. amygdalus amara 
than other varieties of P. amygdalus [86]. For this 
reason, the breath of patients with cyanide-induced 
poisoning has a bitter almond-like odor[87].  
Normally, blood cyanide concentration is lower than 
0.2 mg/L [88]. People with blood cyanide 
concentrations of ≥1 mg/L and plasma lactate 
concentrations of ≥72 mg/dL are considered to be 
patients with suspected cyanide poisoning [89] 
However, it is difficult to determine exactly which 
amounts of bitter almond, if used, lead to poisoning 
[86]. Cyanide-induced poisoning due to bitter almond 
may cause certain complications such as sudden 
headache, dizziness, vomiting, bradycardia, severe 
lactic acidosis, acidosis, hypotension, liver damage, 
walking, fever, seizure, and coma [65, 88]. The action 
mechanism of these complications is that cyanide 
causes intracellular hypoxia by reversibly binding to 
mitochondrial cytochrome oxidase a3 inside the 
mitochondria. Cytochrome oxidase a3 is necessary to 
reduce oxygen to water in the fourth complex of 
oxidative phosphorylation. Cyanide binding to the 
ferric ion in cytochrome oxidase a3 inhibits the 
terminal enzyme in the respiratory chain and stops 
electron transport and oxidative phosphorylation [77]. 
Cyanide-induced poisoning due to high doses of 
bitter almond requires both invasive and support 
treatments to prevent death[50]. Processing plant 
dissections is an effective approach to reduce plant-
induced toxicity. For example, thermal processing 
can stop the enzymatic activity of cyanogenic 
glycoside-contained bitter almond and hence reduce 
its toxicity [90]. 
 
CONCLUSION  
Many studies on the properties of bitter almond and 
amygdalin have been conducted in vitro and in vivo. 
To the best of our knowledge, no randomized clinical 
trials have yet been conducted because of potential 
cyanide-induced poisoning due to amygdalin. 
Therefore, reliable findings on this subject are not 
available, precluding arriving at definite conclusions 
about use of bitter almond kernel. However, in the 
light of the valuable compounds present in bitter 
almond, and their optimal antioxidant and anticancer 
effects and since these antioxidant compounds play a 
highly important role in treating cancer through 
preventing oxidative stress, then future studies are 
recommended to investigate the action mechanisms of 
anticancer effects of bitter almond and amygdalin, the 
most important compound of this plant, in animal 
models to find non toxic and therapeutically efficient 
doses. Next, these doses can be studied in clinical trials 
to treat different cancers.  
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